Renerve Makes First Sale of EmpliQ Amniotic Tissue Products

MT Newswires Live

Oct 14, 2025

Renerve (ASX:RNV) has secured its first commercial sale of the EmpliQ amniotic tissue range, advancing its mission to improve peripheral nerve injury recovery through cutting-edge wound healing solutions, according to a Tuesday filing with the Australian bourse.

The company's EmpliQ range includes three products that accelerate wound healing with growth factors and cytokines, complementing its NervAlign nerve repair products and addressing wounds from surgical sites to diabetic ulcers, per the filing.

The company also established a strategic partnership with Berkeley Biologics to broaden its range of deep dermal and amniotic tissue products, the filing said.

The peripheral nerve repair market is estimated to be worth around $1.6 billion with a growth rate of 17%, while the global dermal and amniotic tissue market is projected to reach around $2.7 billion in 2024, expanding at a 12% compound annual growth rate, the filing added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2575266485"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575266485\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575266485?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-14 15:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575266485","market":"nz","top_or_hot":-1,"title":"Renerve Makes First Sale of EmpliQ Amniotic Tissue Products","media":"MT Newswires Live","content":"<html><body><p> Renerve (ASX:RNV) has secured its first commercial sale of the EmpliQ amniotic tissue range, advancing its mission to improve peripheral nerve injury recovery through cutting-edge wound healing solutions, according to a Tuesday filing with the Australian bourse.</p><p>The company's EmpliQ range includes three products that accelerate wound healing with growth factors and cytokines, complementing its NervAlign nerve repair products and addressing wounds from surgical sites to diabetic ulcers, per the filing.</p><p>The company also established a strategic partnership with Berkeley Biologics to broaden its range of deep dermal and amniotic tissue products, the filing said.</p><p>The peripheral nerve repair market is estimated to be worth around $1.6 billion with a growth rate of 17%, while the global dermal and amniotic tissue market is projected to reach around $2.7 billion in 2024, expanding at a 12% compound annual growth rate, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renerve Makes First Sale of EmpliQ Amniotic Tissue Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenerve Makes First Sale of EmpliQ Amniotic Tissue Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-14 15:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Renerve (ASX:RNV) has secured its first commercial sale of the EmpliQ amniotic tissue range, advancing its mission to improve peripheral nerve injury recovery through cutting-edge wound healing solutions, according to a Tuesday filing with the Australian bourse.</p><p>The company's EmpliQ range includes three products that accelerate wound healing with growth factors and cytokines, complementing its NervAlign nerve repair products and addressing wounds from surgical sites to diabetic ulcers, per the filing.</p><p>The company also established a strategic partnership with Berkeley Biologics to broaden its range of deep dermal and amniotic tissue products, the filing said.</p><p>The peripheral nerve repair market is estimated to be worth around $1.6 billion with a growth rate of 17%, while the global dermal and amniotic tissue market is projected to reach around $2.7 billion in 2024, expanding at a 12% compound annual growth rate, the filing added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RNV.AU","symbol_name":"Renerve Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2575266485","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575266485","pubTimestamp":1760426074,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Renerve  has secured its first commercial sale of the EmpliQ amniotic tissue range, advancing its mission to improve peripheral nerve injury recovery through cutting-edge wound healing solutions, according to a Tuesday filing with the Australian bourse.The company's EmpliQ range includes three products that accelerate wound healing with growth factors and cytokines, complementing its NervAlign nerve repair products and addressing wounds from surgical sites to diabetic ulcers, per the filing.The company also established a strategic partnership with Berkeley Biologics to broaden its range of deep dermal and amniotic tissue products, the filing said.The peripheral nerve repair market is estimated to be worth around $1.6 billion with a growth rate of 17%, while the global dermal and amniotic tissue market is projected to reach around $2.7 billion in 2024, expanding at a 12% compound annual growth rate, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RNV.AU":"Renerve Ltd","BK7126":"医疗保健用品"},"translate_title":"Renerve首次销售EmpliQ羊膜组织产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNV.AU":1},"content_text":"Renerve (ASX:RNV) has secured its first commercial sale of the EmpliQ amniotic tissue range, advancing its mission to improve peripheral nerve injury recovery through cutting-edge wound healing solutions, according to a Tuesday filing with the Australian bourse.The company's EmpliQ range includes three products that accelerate wound healing with growth factors and cytokines, complementing its NervAlign nerve repair products and addressing wounds from surgical sites to diabetic ulcers, per the filing.The company also established a strategic partnership with Berkeley Biologics to broaden its range of deep dermal and amniotic tissue products, the filing said.The peripheral nerve repair market is estimated to be worth around $1.6 billion with a growth rate of 17%, while the global dermal and amniotic tissue market is projected to reach around $2.7 billion in 2024, expanding at a 12% compound annual growth rate, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}